1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow BZL Biologics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase II Trial of Monoclonal Antibody (J591) in Combination With Low-Dose Subcutaneous Interleukin-2 Monoclonal Antibody J591, Recombinant Interleukin-2 - Prostatic Neoplasms | Phase 2 | Completed | BZL Biologics | 2007-01-22 |
Interleukin-2 (1) · J591 monoclonal antibody (1)
United States (1)